ArticleBritish journal of cancer2013

Genetic variation in the GSTM3 promoter confer risk and prognosis of renal cell carcinoma by reducing gene expression.

X Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.